Researchers say a new drug for breast cancer will give patients vital extra time.
The drug called Kadcyla was trialled in Manchester and is now available to patients for the first time.
Doctors say it can extend women's lives by almost six months for those with the most aggressive form of the disease.
Around thirteen hundred women in England could benefit from the drug, which costs £6,000 a month.
Mel Barham reports